Sphingomyelin-degrading pathways in human cells -: Role in cell signalling

被引:29
作者
Levade, T
Andrieu-Abadie, N
Ségui, B
Augé, N
Chatelut, M
Jaffrézou, JP
Salvayre, R
机构
[1] CHU Rangueil, Inst Louis Bugnard, Lab Biochim Malad Metab, INSERM,U466, F-31403 Toulouse 4, France
[2] Inst Claudius Regaud, INSERM, E 9910, Toulouse, France
关键词
sphingomyelin; sphingomyelinase; lysosome; Niemann-Pick disease; ceramide; signalling;
D O I
10.1016/S0009-3084(99)00085-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitous sphingophospholipid sphingomyelin (SM) can be hydrolysed in human cells to ceramide by different sphingomyelinases (SMases). These enzymes exert a dual role, enabling not only the turnover of membrane SM and the degradation of exogenous (lipoprotein) SM, but also the signal-induced generation of the lipid second messenger ceramide. This review focuses on the function(s) of the different SMases in living cells. While both lysosomal and non-lysosomal pathways that ensure SM hydrolysis in intact cells can be distinguished, the precise contribution of each of these SM-cleaving enzymes to the production of ceramide as a signalling molecule remains to be clarified. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:167 / 178
页数:12
相关论文
共 92 条
[11]  
BARNHOLZ Y, 1966, J BIOL CHEM, V241, P3731
[12]  
Basu M, 1997, INDIAN J BIOCHEM BIO, V34, P142
[13]   METABOLISM OF SPHINGOMYELIN BY INTACT CULTURED FIBROBLASTS - DIFFERENTIATION OF NIEMANN-PICK DISEASE TYPE-A AND TYPE-B [J].
BEAUDET, AL ;
MANSCHRECK, AA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 105 (01) :14-19
[14]   CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase [J].
Boesen-de Cock, JGR ;
Tepper, AD ;
de Vries, E ;
van Blitterswijk, WJ ;
Borst, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (13) :7560-7565
[15]   CD28 SIGNALS THROUGH ACIDIC SPHINGOMYELINASE [J].
BOUCHER, LM ;
WIEGMANN, K ;
FUTTERER, A ;
PFEFFER, K ;
MACHLEIDT, T ;
SCHUTZE, S ;
MAK, TW ;
KRONKE, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2059-2068
[16]  
BOUDKER O, 1993, J BIOL CHEM, V268, P22150
[17]   METABOLISM OF SPHINGOMYELIN .2. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN NIEMANN-PICK DISEASE [J].
BRADY, RO ;
KANFER, JN ;
MOCK, MB ;
FREDRICKSON, DS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1966, 55 (02) :366-+
[18]   Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue [J].
Chatelut, M ;
Leruth, M ;
Harzer, K ;
Dagan, A ;
Marchesini, S ;
Gatt, S ;
Salvayre, R ;
Courtoy, P ;
Levade, T .
FEBS LETTERS, 1998, 426 (01) :102-106
[19]   Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies [J].
Chatelut, M ;
Harzer, K ;
Christomanou, H ;
Feunteun, J ;
Pieraggi, MT ;
Paton, BC ;
Kishimoto, Y ;
OBrien, JS ;
Basile, JP ;
Thiers, JC ;
Salvayre, R ;
Levade, T .
CLINICA CHIMICA ACTA, 1997, 262 (1-2) :61-76
[20]   MULTIPLE PATHWAYS ORIGINATE AT THE FAS/APO-1 (CD95) RECEPTOR - SEQUENTIAL INVOLVEMENT OF PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE-C AND ACIDIC SPHINGOMYELINASE IN THE PROPAGATION OF THE APOPTOTIC SIGNAL [J].
CIFONE, MG ;
RONCAIOLI, P ;
DEMARIA, R ;
CAMARDA, G ;
SANTONI, A ;
RUBERTI, G ;
TESTI, R .
EMBO JOURNAL, 1995, 14 (23) :5859-5868